Preteens need only 2 HPV shots—not 3, panel says

October 19, 2016 by Mike Stobbe
This image made available by Merck in October 2016 shows a vial and package for their GARDASIL 9 human papillomavirus vaccine. On Wednesday, Oct. 19, 2016, a government panel said preteens need only get two doses of HPV vaccine instead of three—a move some hope will raise languishing HPV vaccination rates. Health officials say fewer than a third of 13-year-old U.S. boys and girls get all the necessary shots to protect them against human papillomaviruses (Merck via AP)

It may soon be easier for preteens to get the vaccine against cervical cancer. A government panel is recommending they get fewer shots spaced further apart.

Since the HPV vaccine went on sale a decade ago, three doses have been needed. The panel decided Wednesday that two doses are enough.

"It will be simpler now for parents to get their kids the HPV vaccine series, and protect their kids from HPV cancers," said Dr. Nancy Messonnier of the Centers for Disease Control and Prevention.

The vaccine protects against human papillomavirus—or HPV—which can cause cervical cancer, certain other cancers and genital warts. It is commonly spread through sex and, in most cases, the virus doesn't cause any problems. But some infections gradually lead to cancer.

Health officials want kids to get HPV vaccinations at age 11 or 12, well before most first have sex and before they could be infected.

But less than one-third of 13-year-old U.S. boys and girls have gotten three doses. Busy parents have struggled with the old schedule, which called for three trips to the doctor within six months.

"I know people who say 'I can't do that. Why even start?'" said Cynthia Pellegrini, a March of Dimes official who sits on the panel.

Recent studies have shown two doses of the current HPV vaccine—Gardasil 9—work just as well in kids ages 9 to 14. The Food and Drug Administration two weeks ago said it could be given in two doses.

What's more, two doses apparently work better when spaced six to 12 months apart. That means they could be given at annual checkups.

The Advisory Committee on Immunization Practices made the recommendation at a meeting in Atlanta. CDC officials usually adopt the panel's advice and send it to doctors and the public.

The vaccine was first recommended in 2006 for girls, and then for boys in 2011—partly to reduce the spread of HPV to girls.

Vaccination rates have risen very slowly, and health officials have lamented the underuse of a potent cancer prevention tool.

Too many doctors have been timid about promoting the shots, experts say. That's at least partly because some parents have worried the vaccination seems like they are greenlighting their kids to have sex.

But the onerous schedule sure didn't help. "I think it was the icing on the cake" for parents already hesitant about HPV shots, said Dr. William Schaffner, a vaccines expert at Vanderbilt University.

The panel is sticking to three doses for anyone who doesn't get their first shot until they turn 15. That's because they didn't have enough data on how well two doses worked in older kids.

Until recently, there were three HPV vaccines on the market. Now there's only one—Merck & Co.'s Gardasil 9. This month, the company stopped selling an older version. GlaxoSmithKline phased out its vaccine, Cervarix, in the U.S. because of poor sales.

Explore further: Only small increase in US girls getting cervical cancer shot

Related Stories

1 in 5 boys got HPV shot in first year recommended

August 29, 2013

A new report offers a first look at how many boys are getting shots designed to protect girls from cervical cancer. Health officials say the number getting vaccinated so far is a good start.

New HPV vaccine strengthens cancer protection

December 10, 2014

The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.

Three doses of HPV vaccine recommended against genital warts

February 11, 2014

Two doses of vaccine against human papillomavirus (HPV) provide good protection against genital warts, but three doses is better according to an extensive register study by researchers at Karolinska Institutet in Sweden. ...

HPV-cancers on rise in United States

July 7, 2016

The number of cancers associated with the human papillomavirus (HPV) is on the rise in the United States, reaching nearly 39,000 each year, a US government report said Thursday.

Recommended for you

'Diet' products can make you fat, study shows

April 25, 2017

High-fat foods are often the primary target when fighting obesity, but sugar-laden "diet" foods could be contributing to unwanted weight gain as well, according to a new study from the University of Georgia.

Exercise good for the spine

April 24, 2017

A world-first study has shown that specific physical activity benefits the discs in our spines and may help to prevent and manage spinal pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.